|Articles|September 1, 2011

Thorne Research Markets High-Bioavailability CoQ10 Supplement

The company says it features a unique, tri-lipid gel-based formulation that increases absorption by up to tenfold.

Dietary supplements marketer Thorne Research Inc., which largely serves the healthcare practitioner market, has acquired exclusive global rights to market Q-Cell, which the company calls a high-bioavailability CoQ10 supplement.

The company says that Q-Cell, formerly marketed under the name Q-Best, features a unique, tri-lipid gel-based formulation that increases absorption by up to tenfold when compared with dry-powder CoQ10 supplements. The company says that Q-Cell’s formulation enables the soft gel to prevent crystallization, which can often disrupt the absorption process when metabolized in humans.


Related to this article

Denis Neville, CoreFX Ingredients
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Denis Neville, founder and CEO of CoreFX Ingredients, about the launch of CreaSHLD-IN.
Brian Appell Givaudan
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Appell, product manager, Givaudan, about the launch of NovaBerin for the metabolic health market.
Elzaphan Hotam
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.
Komal Baldwa, founder and CEO of aspurus
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.